✦ LIBER ✦

Pancreatic sarcoidosis mimicking pancreatic cancer

✍ Scribed by Barry R. Sagalow; Cynthia L. Miller; Richard J. Wechsler

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 288 KB
Volume: 16
Category: Article
ISSN: 0091-2751
DOI: 10.1002/jcu.1870160213

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pancreatic sarcoidosis: MRI features

✍ Ronaldo H. Baroni; Ivan Pedrosa; Ekaterini Tavernaraki; Jeffrey Goldsmith; Neil 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 657 KB

## Abstract Pancreatic sarcoidosis is a rare entity, and few reports in the literature describe the CT aspects of the disease. We report the MR features of a pathologically‐confirmed case of pancreatic sarcoidosis, which presented as multiple pancreatic masses with low signal intensity on T1‐weight

Afferent-loop obstruction mimicking acut

Afferent-loop obstruction mimicking acute pancreatitis

✍ W. G. Everett; D. Sampson 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

Pancreatic arteriography, transhepatic p

Pancreatic arteriography, transhepatic pancreatic venography, and pancreatic venous sampling in diagnosis of pancreatic cancer

✍ Josef Rosch; Frederick S. Keller 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB

Familial pancreatic cancer

✍ D. K. Bartsch 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 1 views

Pancreatic cancer microenvironment

✍ Jörg Kleeff; Philipp Beckhove; Irene Esposito; Stephan Herzig; Peter E. Huber; J 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 539 KB

## Abstract Pancreatic ductal adenocarcinoma remains an extremely aggressive malignancy that is virtually therapy‐resistant and has therefore one of the worst prognoses of all human cancers. The focus of research, which had been placed mostly on genetic and epigenetic alterations of the cancer cell

Brachytherapy and pancreatic cancer

✍ William R. Bodner; Basil S. Hilaris 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

Advances in diagnostic and therapeutic technology have not appreciably changed the outlook of patients with pancreatic cancer. While those patients presenting with localized resectable disease have the best prognosis, local control and intra-abdominal metastases remain significant obstacles to survi